Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CAPECITABINE Cause Transient ischaemic attack? 92 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 92 reports of Transient ischaemic attack have been filed in association with CAPECITABINE (Capecitabine). This represents 0.1% of all adverse event reports for CAPECITABINE.

92
Reports of Transient ischaemic attack with CAPECITABINE
0.1%
of all CAPECITABINE reports
5
Deaths
49
Hospitalizations

How Dangerous Is Transient ischaemic attack From CAPECITABINE?

Of the 92 reports, 5 (5.4%) resulted in death, 49 (53.3%) required hospitalization, and 7 (7.6%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CAPECITABINE. However, 92 reports have been filed with the FAERS database.

What Other Side Effects Does CAPECITABINE Cause?

Diarrhoea (9,277) Nausea (6,248) Palmar-plantar erythrodysaesthesia syndrome (5,294) Fatigue (5,018) Death (4,422) Vomiting (4,111) Disease progression (3,808) Off label use (3,193) Malignant neoplasm progression (2,425) Asthenia (2,352)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which CAPECITABINE Alternatives Have Lower Transient ischaemic attack Risk?

CAPECITABINE vs CAPIVASERTIB CAPECITABINE vs CAPLACIZUMAB CAPECITABINE vs CAPLACIZUMAB-YHDP CAPECITABINE vs CAPMATINIB CAPECITABINE vs CAPREOMYCIN

Related Pages

CAPECITABINE Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack CAPECITABINE Demographics